期刊文献+

盐酸氨溴索可减少心内直视手术后肺不张 被引量:5

Cyclohexanol Hydrochloride Can Reduce Atelectasis after Heart Operation
暂未订购
导出
摘要 【目的】观察盐酸氨溴索 (沐舒痰 )减少心内直视术后呼吸道并发症的作用。【方法】 10 0例心内直视术后患者 ,随机分为实验组和对照组各 5 0例 ,实验组术后开始静脉应用盐酸氨溴索 ,对照组应用LP(陈皮、茴香、远志、吐温的合剂 )。观察比较两组患者术后 3~ 14d咳痰困难程度、痰液粘稠度、排痰难度、肺部罗音、呼吸系统并发症及副作用。【结果】实验组痰液粘稠度、排痰难度、肺部罗音明显低于对照组 (14% ,P<0 0 5 ) ,肺不张发生率为 4% ,明显低于对照组 (14% ,P <0 0 5 ) ,两组均未见明显副作用。【结论】盐酸氨溴索应用于心内直视术后可显著减少肺不张并发症。 Objective To observe the effects of cyclohexanol hydrochloride (Mucosolvan) on reducing respiratory complications after heart operations. Methods One hundred patients were randomly divided into the studied and control group. Each group consisted of fifty patients. Cyclohexanol hydrochloride was infused intravenously in the studied group and LP (the mixture of ChenPi, HuiXiang, YuanZhi and AnYuan) were used in the control group. 3~14 d after heart operations, density of phlegm, difficulty in expectoration, pneumonic rales, respiratory complications and side effects of drugs were observed and compared. Results The prevalence of high density of phlegm, difficulty in expectoration and pneumonic rales were markedly less in the studied group than in the control (P<0.05). The prevalence of atelectasis in the studied group was 4%, much lower than that in the control group(14%, P<0.05). No obvious side effects were found in the two groups. Conclusions Administration of cyclohexanol hydrochloride in patients after heart operations can reduce the respiratory complications, especially atelectasis.
出处 《中山医科大学学报》 CSCD 北大核心 2001年第4期286-288,共3页 Academic Journal of Sun Yat-sen University of Medical Sciences
关键词 盐酸氨溴索 心内直视手术 术后 肺不张 预防 ambroxol/therapeutic use cardial surgical procedures atelectasis/prevention&control sputum
  • 相关文献

参考文献1

共引文献7

同被引文献16

  • 1周志荣,李振林.盐酸溴环己胺醇的临床应用[J].国外医学(呼吸系统分册),1995,15(2):97-98. 被引量:11
  • 2罗文杰,薛庆生.沐舒坦对老年患者术后呼吸系统并发症的预防作用[J].临床麻醉学杂志,2005,21(9):603-604. 被引量:9
  • 3Prevention of chronic bronchitis exacerbation with ambrexol ( Mucoeolvan retard), Respiration, 1989,55 ( suppL 1) :84 - 96.
  • 4Hoblfeld J,Fabel H,Hamm H.The role of pulmonary surfactant in obstructive airways disease.Eur Resp J,1997,10(2):482.
  • 5Fegiz G.Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery:double2blind Italian multicenter clinical study versus placebo.Lung,1991,169 (2):69.
  • 6Von Seefeld H,Weiss J M,Rensch H.The role of pulmonary surfactant in obstructive airway disease.Fortschr Med,1984,102 (39):977.
  • 7Fegiz G. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: dcebled-blind Italian multicenter clinical study remus placebo[J]. Lung, 1991,169(2) :69-76.
  • 8Hoblfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obsnuctive airways disease[J]. Eur Resp J,1997,10(2) :482.
  • 9Gillissen A,Bartling A,Schoen S,et al. Antioxidant function of ambroxol in mononuclear and polymorphonuclear ceils in vitro[J].Lung, 1997,175 (4) :235-242.
  • 10Nemcekova E ,Nosalova G,Franova S. Ambroxol and protective retiexes of the respiratory tract[J]. Bratisl Lek Listy,1998,99(2) :111-115.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部